Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
NuVasive Inc. announced a flurry of new executive assignments yesterday as it reorganizes its leadership team under new CEO Gregory Lucier, who took over the position in May from ousted Alex Lukianov.
NuVasive 14-year vet Pat Miles will stay on as COO and president, a position he was appointed to earlier this year, NuVasive said. Current CFO Quentin Blackford will also hold his spot with the company, with the added title of executive vice president. Read more
NaviMed Capital today said it raised its 1st fund, a $110 million pool it plans to use to back “lower middle-market healthcare businesses” in the services, IT, hospital products and distribution sectors.
The Washington, D.C.-based private equity shop said its 1st investment from the fund went to healthcare risk management company Lucent Health Solutions. Read more
Johnson & Johnson reported 2nd-quarter results that beat expectations on Wall Street, despite a nearly 9% top-line slide.
The New Brunswick, N.J.-based healthcare conglomerate posted profits of $4.52 billion, or $1.61 per share, on sales of $17.79 billion for the 3 months ended June 30, for bottom-line growth of 4.4% on an -8.8% sales decline. Read more